HealthTree

Your Feed

Filter by

See content from

Back to the latest

Patrick and Kushla's New Zealand Multiple Myeloma Story

Patrick and Kushla's New Zealand Multiple Myeloma Story image

Clinical Trial: New Phase II Trial Opens for Pfizer's Multiple Myeloma Bispecific Antibody Elrantamab

Clinical Trial: New Phase II Trial Opens for Pfizer's Multiple Myeloma Bispecific Antibody Elrantamab image

Thumbnail for (Guest Lecture) February 2021 Modifiable risk factors that affect Myeloma Pt. 2

Playlist: Nutrition and Diet as a Biologically-Based Therapy

(Guest Lecture) February 2021 Modifiable risk factors that affect Myeloma Pt. 2

Video details & playlist

A Prior Cancer Diagnosis and Later Development of Multiple Myeloma

A Prior Cancer Diagnosis and Later Development of Multiple Myeloma image

Things To Consider When Returning To Work During Or After Treatment

Things To Consider When Returning To Work During Or After Treatment image

Michelle Peterson's Myeloma Journey: A Non-Working Twin Allo Transplant But a Great Outcome

Michelle Peterson's Myeloma Journey: A Non-Working Twin Allo Transplant But a Great Outcome image

HealthTree University: Myeloma Bone Disease (Part 2 of 5)

HealthTree University: Myeloma Bone Disease (Part 2 of 5) image

Avoiding Caregiver Burnout: Caregiver Coaches Offer Advice

Avoiding Caregiver Burnout: Caregiver Coaches Offer Advice image

John Miller's Expanded Vision after His Multiple Myeloma Stem Cell Transplant

John Miller's Expanded Vision after His Multiple Myeloma Stem Cell Transplant image

COVID Vaccination Guidelines for Myeloma Patients Released

COVID Vaccination Guidelines for Myeloma Patients Released image

Interfering with a Specific Gene (IRF4) to Treat Multiple Myeloma

Interfering with a Specific Gene (IRF4) to Treat Multiple Myeloma image

Post-ASH January 30, 2021 Myeloma round Table image

Post-ASH January 30, 2021 Myeloma round Table

11:00AM - 02:00PM EST

Watch Recording

MCRT Webcast: Side Effects of Myeloma Treatment

MCRT Webcast: Side Effects of Myeloma Treatment image

Plasma Cell Leukemia Support Group Launch image

Plasma Cell Leukemia Support Group Launch

11:00AM - 12:00PM MST

Watch Recording

TMA, a Rare Complication of Stem Cell Transplants

TMA, a Rare Complication of Stem Cell Transplants image

ONJ and Multiple Myeloma

ONJ and Multiple Myeloma image

Thumbnail for (Guest Lecture) January 2021 Modifiable risk factors that affect Myeloma Pt. 1

Playlist: Nutrition and Diet as a Biologically-Based Therapy

(Guest Lecture) January 2021 Modifiable risk factors that affect Myeloma Pt. 1

Video details & playlist

What's Coming in 2021 in Multiple Myeloma with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Dr. Orlowski shares new treatments for patients with MGUS and smoldering myeloma

What's Coming in 2021 in Multiple Myeloma with Robert Orlowski, MD, PhD, MD Anderson Cancer Center image

Listen to episode

MCRT Webcast: High-Risk Disease Essentials

MCRT Webcast: High-Risk Disease Essentials image

Blood Type and Multiple Myeloma Outcomes

Blood Type and Multiple Myeloma Outcomes image

Pesticide Use Linked to Myeloma Precursor Conditions

Pesticide Use Linked to Myeloma Precursor Conditions image

MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma

MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma image

Underweight or Overweight: Myeloma Patients Have the Best Outcomes with Stable, Healthy Weight

Underweight or Overweight: Myeloma Patients Have the Best Outcomes with Stable, Healthy Weight image

Thumbnail for Can only a percentage of your myeloma cells possess 17p deletion? How is that percentage determined?

Playlist: Chromosomal and Gene Abnormalities in Myeloma

Can only a percentage of your myeloma cells possess 17p deletion? How is that percentage determined?

Video details & playlist

More from HealthTree